• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    7.81 Down 0.05(0.64%) Jan 30, 4:00PM EST
    |After Hours : 8.00 Up 0.19 (2.43%) Jan 30, 7:49PM EST
    Add to Portfolio
    Prev Close:7.86
    Open:7.82
    Bid:6.03 x 600
    Ask:N/A
    1y Target Est:10.19
    Beta:1.41
    Next Earnings Date:N/A
    Day's Range:7.74 - 8.07
    52wk Range:3.34 - 8.07
    Volume:4,886,077
    Avg Vol (3m):4,434,190
    Market Cap:1.86B
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 0.64%1.86B
    MRKDown 2.92%171.85B
    NVSDown 1.77%233.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):57.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.31
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback